A CRYSTALLINE FORM OF A SALT OF A MORPHOLINO SULFONYL INDOLE DERIVATIVE AND A PROCESS FOR ITS PREPARATION

The present invention relates to a crystalline form of a pharmaceutically acceptable salt of a morpholino sulphonyl indole derivative, that is capable of inhibiting, modulating and/or regulating Insulin-Like-Growth Factor I Receptor and Insulin Receptor. The present invention also relates to a proce...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: CHENNAMSETTY, SUNEEL, MANOHAR, BABU, JOSHI, KISHOR, HULAWALE, YOGESH, CHINCHWADE, YOGESH, HARIHARAN, SIVARAMAKRISHNAN, SIVAKUMAR, MEENAKSHI, PARAMASIVAN, SELVAM
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator CHENNAMSETTY, SUNEEL, MANOHAR, BABU
JOSHI, KISHOR
HULAWALE, YOGESH
CHINCHWADE, YOGESH
HARIHARAN, SIVARAMAKRISHNAN
SIVAKUMAR, MEENAKSHI
PARAMASIVAN, SELVAM
description The present invention relates to a crystalline form of a pharmaceutically acceptable salt of a morpholino sulphonyl indole derivative, that is capable of inhibiting, modulating and/or regulating Insulin-Like-Growth Factor I Receptor and Insulin Receptor. The present invention also relates to a process for the preparation of the crystalline form of said compound. Formula (I): La présente invention concerne une forme cristalline d'un sel pharmaceutiquement acceptable d'un dérivé de morpholinosulfonylindole, qui peut inhiber, moduler et/ou réguler le récepteur du facteur de croissance analogue à l'insuline I et le récepteur de l'insuline. La présente invention concerne également un procédé de préparation de la forme cristalline dudit composé. Formule (I) :
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2012143879A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2012143879A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2012143879A13</originalsourceid><addsrcrecordid>eNqNjMEKwjAQRHvxIOo_LHgWbCuox6XZ0ECaDUms9FSKRBBEC_X_MaIf4GlmeI-ZZzeEynU-oNbKEEh2DbAEBI86fFvDztacMIM_acmm06CMYE0gyKkWg2oJ0IjkWscVef_5ARV82mTRJYPNMptdh_sUV79cZGtJoao3cXz2cRqHS3zEV3_mYpsX-a487I-Yl_9Zb_N7Nok</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>A CRYSTALLINE FORM OF A SALT OF A MORPHOLINO SULFONYL INDOLE DERIVATIVE AND A PROCESS FOR ITS PREPARATION</title><source>esp@cenet</source><creator>CHENNAMSETTY, SUNEEL, MANOHAR, BABU ; JOSHI, KISHOR ; HULAWALE, YOGESH ; CHINCHWADE, YOGESH ; HARIHARAN, SIVARAMAKRISHNAN ; SIVAKUMAR, MEENAKSHI ; PARAMASIVAN, SELVAM</creator><creatorcontrib>CHENNAMSETTY, SUNEEL, MANOHAR, BABU ; JOSHI, KISHOR ; HULAWALE, YOGESH ; CHINCHWADE, YOGESH ; HARIHARAN, SIVARAMAKRISHNAN ; SIVAKUMAR, MEENAKSHI ; PARAMASIVAN, SELVAM</creatorcontrib><description>The present invention relates to a crystalline form of a pharmaceutically acceptable salt of a morpholino sulphonyl indole derivative, that is capable of inhibiting, modulating and/or regulating Insulin-Like-Growth Factor I Receptor and Insulin Receptor. The present invention also relates to a process for the preparation of the crystalline form of said compound. Formula (I): La présente invention concerne une forme cristalline d'un sel pharmaceutiquement acceptable d'un dérivé de morpholinosulfonylindole, qui peut inhiber, moduler et/ou réguler le récepteur du facteur de croissance analogue à l'insuline I et le récepteur de l'insuline. La présente invention concerne également un procédé de préparation de la forme cristalline dudit composé. Formule (I) :</description><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2012</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20121026&amp;DB=EPODOC&amp;CC=WO&amp;NR=2012143879A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20121026&amp;DB=EPODOC&amp;CC=WO&amp;NR=2012143879A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CHENNAMSETTY, SUNEEL, MANOHAR, BABU</creatorcontrib><creatorcontrib>JOSHI, KISHOR</creatorcontrib><creatorcontrib>HULAWALE, YOGESH</creatorcontrib><creatorcontrib>CHINCHWADE, YOGESH</creatorcontrib><creatorcontrib>HARIHARAN, SIVARAMAKRISHNAN</creatorcontrib><creatorcontrib>SIVAKUMAR, MEENAKSHI</creatorcontrib><creatorcontrib>PARAMASIVAN, SELVAM</creatorcontrib><title>A CRYSTALLINE FORM OF A SALT OF A MORPHOLINO SULFONYL INDOLE DERIVATIVE AND A PROCESS FOR ITS PREPARATION</title><description>The present invention relates to a crystalline form of a pharmaceutically acceptable salt of a morpholino sulphonyl indole derivative, that is capable of inhibiting, modulating and/or regulating Insulin-Like-Growth Factor I Receptor and Insulin Receptor. The present invention also relates to a process for the preparation of the crystalline form of said compound. Formula (I): La présente invention concerne une forme cristalline d'un sel pharmaceutiquement acceptable d'un dérivé de morpholinosulfonylindole, qui peut inhiber, moduler et/ou réguler le récepteur du facteur de croissance analogue à l'insuline I et le récepteur de l'insuline. La présente invention concerne également un procédé de préparation de la forme cristalline dudit composé. Formule (I) :</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2012</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjMEKwjAQRHvxIOo_LHgWbCuox6XZ0ECaDUms9FSKRBBEC_X_MaIf4GlmeI-ZZzeEynU-oNbKEEh2DbAEBI86fFvDztacMIM_acmm06CMYE0gyKkWg2oJ0IjkWscVef_5ARV82mTRJYPNMptdh_sUV79cZGtJoao3cXz2cRqHS3zEV3_mYpsX-a487I-Yl_9Zb_N7Nok</recordid><startdate>20121026</startdate><enddate>20121026</enddate><creator>CHENNAMSETTY, SUNEEL, MANOHAR, BABU</creator><creator>JOSHI, KISHOR</creator><creator>HULAWALE, YOGESH</creator><creator>CHINCHWADE, YOGESH</creator><creator>HARIHARAN, SIVARAMAKRISHNAN</creator><creator>SIVAKUMAR, MEENAKSHI</creator><creator>PARAMASIVAN, SELVAM</creator><scope>EVB</scope></search><sort><creationdate>20121026</creationdate><title>A CRYSTALLINE FORM OF A SALT OF A MORPHOLINO SULFONYL INDOLE DERIVATIVE AND A PROCESS FOR ITS PREPARATION</title><author>CHENNAMSETTY, SUNEEL, MANOHAR, BABU ; JOSHI, KISHOR ; HULAWALE, YOGESH ; CHINCHWADE, YOGESH ; HARIHARAN, SIVARAMAKRISHNAN ; SIVAKUMAR, MEENAKSHI ; PARAMASIVAN, SELVAM</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2012143879A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2012</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>CHENNAMSETTY, SUNEEL, MANOHAR, BABU</creatorcontrib><creatorcontrib>JOSHI, KISHOR</creatorcontrib><creatorcontrib>HULAWALE, YOGESH</creatorcontrib><creatorcontrib>CHINCHWADE, YOGESH</creatorcontrib><creatorcontrib>HARIHARAN, SIVARAMAKRISHNAN</creatorcontrib><creatorcontrib>SIVAKUMAR, MEENAKSHI</creatorcontrib><creatorcontrib>PARAMASIVAN, SELVAM</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CHENNAMSETTY, SUNEEL, MANOHAR, BABU</au><au>JOSHI, KISHOR</au><au>HULAWALE, YOGESH</au><au>CHINCHWADE, YOGESH</au><au>HARIHARAN, SIVARAMAKRISHNAN</au><au>SIVAKUMAR, MEENAKSHI</au><au>PARAMASIVAN, SELVAM</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>A CRYSTALLINE FORM OF A SALT OF A MORPHOLINO SULFONYL INDOLE DERIVATIVE AND A PROCESS FOR ITS PREPARATION</title><date>2012-10-26</date><risdate>2012</risdate><abstract>The present invention relates to a crystalline form of a pharmaceutically acceptable salt of a morpholino sulphonyl indole derivative, that is capable of inhibiting, modulating and/or regulating Insulin-Like-Growth Factor I Receptor and Insulin Receptor. The present invention also relates to a process for the preparation of the crystalline form of said compound. Formula (I): La présente invention concerne une forme cristalline d'un sel pharmaceutiquement acceptable d'un dérivé de morpholinosulfonylindole, qui peut inhiber, moduler et/ou réguler le récepteur du facteur de croissance analogue à l'insuline I et le récepteur de l'insuline. La présente invention concerne également un procédé de préparation de la forme cristalline dudit composé. Formule (I) :</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO2012143879A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title A CRYSTALLINE FORM OF A SALT OF A MORPHOLINO SULFONYL INDOLE DERIVATIVE AND A PROCESS FOR ITS PREPARATION
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T21%3A53%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CHENNAMSETTY,%20SUNEEL,%20MANOHAR,%20BABU&rft.date=2012-10-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2012143879A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true